The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Cancer Risks Associated With Germline Mutations in <emph type="ital">MLH1</emph>, <emph type="ital">MSH2</emph>, and <emph type="ital">MSH6</emph> Genes in Lynch Syndrome
Open accessAbstract
CONTEXT: Providing accurate estimates of cancer risks is a major challenge in the clinical management of Lynch syndrome. OBJECTIVE: To estimate the age-specific cumulative risks of developing various tumors using a large series of families with mutations of the MLH1, MSH2, and MSH6 genes. DESIGN, SETTING, AND PARTICIPANTS: Families with Lynch syndrome enrolled between January 1, 2006, and December 31, 2009, from 40 French cancer genetics clinics participating in the ERISCAM (Estimation des Risques de Cancer chez les porteurs de mutation des gènes MMR) study; 537 families with segregating mutated genes (248 with MLH1; 256 with MSH2; and 33 with MSH6) were analyzed. MAIN OUTCOME MEASURE: Age-specific cumulative cancer risks estimated using the genotype restricted likelihood (GRL) method accounting for ascertainment bias. RESULTS: Significant differences in estimated cumulative cancer risk were found between the 3 mutated genes (P = .01). The estimated cumulative risks of colorectal cancer by age 70 years were 41% (95% confidence intervals [CI], 25%-70%) for MLH1 mutation carriers, 48% (95% CI, 30%-77%) for MSH2, and 12% (95% CI, 8%-22%) for MSH6. For endometrial cancer, corresponding risks were 54% (95% CI, 20%-80%), 21% (95% CI, 8%-77%), and 16% (95% CI, 8%-32%). For ovarian cancer, they were 20% (95% CI, 1%-65%), 24% (95% CI, 3%-52%), and 1% (95% CI, 0%-3%). The estimated cumulative risks by age 40 years did not exceed 2% (95% CI, 0%-7%) for endometrial cancer nor 1% (95% CI, 0%-3%) for ovarian cancer, irrespective of the gene. The estimated lifetime risks for other tumor types did not exceed 3% with any of the gene mutations. CONCLUSIONS: MSH6 mutations are associated with markedly lower cancer risks than MLH1 or MSH2 mutations. Lifetime ovarian and endometrial cancer risks associated with MLH1 or MSH2 mutations were high but do not increase appreciably until after the age of 40 years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
VASEN, H., WATSON, P., MECKLIN, J., & LYNCH, H. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70510-x · Cited by 2,519
Lynch, H. T., & de la Chapelle, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra012242 · Cited by 2,203
Meta-Analysis of BRCA1 and BRCA2 Penetrance
Chen, S., & Parmigiani, G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.1066 · Cited by 1,802
Järvinen, H. J., Aarnio, M., Mustonen, H., Aktan–Collan, K., Aaltonen, L. A., Peltomäki, P., Chapelle, A. D. L., & Mecklin, J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70168-5 · Cited by 1,337
Cancer risk in mutation carriers of DNA-mismatch-repair genes
Aarnio, M., Sankila, R., Pukkala, E., Salovaara, R., Aaltonen, L. A., de la Chapelle, A., Peltom�ki, P., Mecklin, J.-P., & J�rvinen, H. J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990412)81:2<214::aid-ijc8>3.0.co;2-l · Cited by 1,278
Rodriguez-Bigas, M. A., Boland, C. R., Hamilton, S. R., Henson, D. E., Srivastava, S., Jass, J. R., Khan, P. M., Lynch, H., Smyrk, T., Perucho, M., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.23.1758 · Cited by 1,137
Prophylactic Surgery to Reduce the Risk of Gynecologic Cancers in the Lynch Syndrome
Schmeler, K. M., Lynch, H. T., Chen, L.-M., Munsell, M. F., Soliman, P. T., Clark, M. B., Daniels, M. S., White, K. G., Boyd-Rogers, S. G., Conrad, P. G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052627 · Cited by 794
Cancer risk associated with germline DNA mismatch repair gene mutations
Dunlop, M. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.1.105 · Cited by 688
Lindor, N. M., Petersen, G. M., Hadley, D. W., Kinney, A. Y., Miesfeldt, S., Lu, K. H., Lynch, P., Burke, W., & Press, N. (2006) · JAMA · doi:10.1001/jama.296.12.1507 · Cited by 629
The risk of extra‐colonic, extra‐endometrial cancer in the Lynch syndrome
Watson, P., Vasen, H. F. A., Mecklin, J., Bernstein, I., Aarnio, M., Järvinen, H. J., Myrhøj, T., Sunde, L., Wijnen, J. T., & Lynch, H. T. (2008) · International Journal of Cancer · doi:10.1002/ijc.23508 · Cited by 596
Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)
Vasen, H. F. A., Möslein, G., Alonso, A., Bernstein, I., Bertario, L., Blanco, I., Burn, J., Capella, G., Engel, C., Frayling, I., et al. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2007.048991 · Cited by 554
Cancer incidence and mortality in France over the period 1980–2005
Belot, A., Grosclaude, P., Bossard, N., Jougla, E., Benhamou, E., Delafosse, P., Guizard, A.-V., Molinié, F., Danzon, A., Bara, S., et al. (2008) · Revue d'Épidémiologie et de Santé Publique · doi:10.1016/j.respe.2008.03.117 · Cited by 546
Risk of Pancreatic Cancer in Families With Lynch Syndrome
Kastrinos, F. (2009) · JAMA · doi:10.1001/jama.2009.1529 · Cited by 544
Hendriks, Y. M. C., Wagner, A., Morreau, H., Menko, F., Stormorken, A., Quehenberger, F., Sandkuijl, L., Møller, P., Genuardi, M., van Houwelingen, H., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.068 · Cited by 426
Cancer Risk in Hereditary Nonpolyposis Colorectal Cancer Syndrome: Later Age of Onset
HAMPEL, H., STEPHENS, J., PUKKALA, E., SANKILA, R., AALTONEN, L., MECKLIN, J., & DELACHAPELLE, A. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.011 · Cited by 407
Vasen, H. F. A., Stormorken, A., Menko, F. H., Nagengast, F. M., Kleibeuker, J. H., Griffioen, G., Taal, B. G., Moller, P., & Wijnen, J. T. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.20.4074 · Cited by 406
Risks of Lynch Syndrome Cancers for MSH6 Mutation Carriers
Baglietto, L., Lindor, N. M., Dowty, J. G., White, D. M., Wagner, A., Gomez Garcia, E. B., Vriends, A. H. J. T., Dutch Lynch Syndrome Study Group, Cartwright, N. R., Barnetson, R. A., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp473 · Cited by 376
Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome
Stoffel, E., Mukherjee, B., Raymond, V. M., Tayob, N., Kastrinos, F., Sparr, J., Wang, F., Bandipalliam, P., Syngal, S., & Gruber, S. B. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.039 · Cited by 360
Barrow, E., Robinson, L., Alduaij, W., Shenton, A., Clancy, T., Lalloo, F., Hill, J., & Evans, D. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2008.01125.x · Cited by 318
Quehenberger, F., Vasen, H. F. A., & van Houwelingen, H. C. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.024299 · Cited by 279
Plaschke, J., Engel, C., Krüger, S., Holinski-Feder, E., Pagenstecher, C., Mangold, E., Moeslein, G., Schulmann, K., Gebert, J., von Knebel Doeberitz, M., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.033 · Cited by 245
Risk and Epidemiological Time Trends of Gastric Cancer in Lynch Syndrome Carriers in The Netherlands
Capelle, L. G., Van Grieken, N. C. T., Lingsma, H. F., Steyerberg, E. W., Klokman, W. J., Bruno, M. J., Vasen, H. F. A., & Kuipers, E. J. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.10.051 · Cited by 230
Jenkins, M. A., Baglietto, L., Dowty, J. G., Van Vliet, C. M., Smith, L., Mead, L. J., Macrae, F. A., St. John, D. J. B., Jass, J. R., Giles, G. G., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.01.002 · Cited by 171
Terdiman, J. P., Gum, J. R., Conrad, P. G., Miller, G. A., WEINBERG, V. K., Crawley, S., Levin, T. R., Reeves, C., Schmitt, A., Hepburn, M., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.20874 · Cited by 155
Risk-Reducing Salpingo-Oophorectomy in Patients With Germline Mutations in BRCA1 or BRCA2
Kauff, N. D., & Barakat, R. R. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.3449 · Cited by 136
Recommendations to improve identification of hereditary and familial colorectal cancer in Europe
Vasen, H. F. A., Möslein, G., Alonso, Á., Aretz, S., Bernstein, I., Bertario, L., Blanco, I., Bülow, S., Burn, J., Capellá, G., et al. (2009) · Familial Cancer · doi:10.1007/s10689-009-9291-3 · Cited by 120
Barrow, E., Alduaij, W., Robinson, L., Shenton, A., Clancy, T., Lalloo, F. I., Hill, J., & Evans, D. G. (2008) · Clinical Genetics · doi:10.1111/j.1399-0004.2008.01035.x · Cited by 100
Estimating cancer risk in HNPCC by the GRL method
Alarcon, F., Lasset, C., Carayol, J., Bonadona, V., Perdry, H., Desseigne, F., Wang, Q., & Bonaïti‐Pellié, C. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201843 · Cited by 64
Self-citationChoi, Y., Cotterchio, M., McKeown‐Eyssen, G., Monga, N., Bapat, B. V., Boyd, K., Gallinger, S., McLaughlin, J. R., Aronson, M. D., & Briollais, L. (2009) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-7-14 · Cited by 58
Carayol, J., & Bonaïti‐Pellié, C. (2004) · Genetic Epidemiology · doi:10.1002/gepi.20007 · Cited by 47
Bonaïti, B., Bonadona, V., Perdry, H., Andrieu, N., & Bonaïti‐Pellié, C. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.158 · Cited by 15
Self-citation
Cited by
Ovarian cancer statistics, 2018
Torre, L. A., Trabert, B., DeSantis, C. E., Miller, K. D., Samimi, G., Runowicz, C. D., Gaudet, M. M., Jemal, A., & Siegel, R. L. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21456 · Cited by 3,492
Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors
Rawla, P., Sunkara, T., & Barsouk, A. (2019) · Gastroenterology Review · doi:10.5114/pg.2018.81072 · Cited by 2,323
Syngal, S., Brand, R. E., Church, J. M., Giardiello, F. M., Hampel, H. L., & Burt, R. W. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.435 · Cited by 1,662
Epidemiology of ovarian cancer: a review
Brett M., R., Brett M., R., Jennifer B., P., Thomas A., S., Jennifer B., P., & Thomas A., S. (2017) · Cancer Biology & Medicine · doi:10.20892/j.issn.2095-3941.2016.0084 · Cited by 1,524
Morice, P., Leary, A., Creutzberg, C., Abu-Rustum, N., & Darai, E. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00130-0 · Cited by 1,514
Metadata
- Authors
- Bonadona, V.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2011-06-08
- Volume
- 305
- Issue
- 22
- Pages
- 2304
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2159899668
- Cited by
- 1,103
- References
- 31
- FWCI
- 38.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.